Lance Alstodt is CEO & President +1 at BioRestorative Therapies, Inc. (BRTX). They have made 33 open-market trades across 1 company since 2019, most recently 2025-10-06.
CIK 0001756228
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
33 open-market purchases totalling $138K since 2019, never a sale. Across 33 scored buys the stock is down 1.9% at ninety days, and 3.1 points behind the S&P over the same stretch.
33 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| BRTX | 187,497 | $283K |
Shares reported on the most recent Form 4, priced at the 2025-10-20 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 30% | 33% | 45% |
| Avg Move | -5.3% | -5.2% | -1.9% |
| Alpha | -12.5% | -5.5% | -3.1% |
| Scored | 33 | 33 | 33 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BRTX | BUY | 2023-09-15 | 2023-09-18 | $1.70 | $4K | -9.2% | +6.3% | +10.3% |
| BRTX | BUY | 2023-09-13 | 2023-09-13 | $1.53 | $1K | -0.6% | +43.5% | +19.5% |
| BRTX | BUY | 2023-09-06 | 2023-09-06 | $1.96 | $6K | -6.5% | +15.8% | -4.3% |
| BRTX | BUY | 2023-07-25 | 2023-07-25 | $2.44 | $10K | +13.2% | -2.8% | -24.4% |
| BRTX | BUY | 2023-02-01 | 2023-02-02 | $3.10 | $1K | -5.7% | +12.3% | +26.4% |
| BRTX | BUY | 2023-01-27 | 2023-01-30 | $3.01 | $602 | -1.7% | -3.8% | +42.1% |
| BRTX | BUY | 2023-01-20 | 2023-01-24 | $3.14 | $627 | +1.3% | -7.3% | +27.7% |
| BRTX | BUY | 2023-01-18 | 2023-01-20 | $3.11 | $1K | +0.3% | -7.2% | +22.5% |
| BRTX | BUY | 2023-01-09 | 2023-01-10 | $3.08 | $308 | -2.6% | -8.1% | +15.6% |
| BRTX | BUY | 2022-12-23 | 2022-12-28 | $3.01 | $903 | +11.7% | +6.7% | +15.2% |
| BRTX | BUY | 2022-12-07 | 2022-12-07 | $2.99 | $5K | -3.8% | +4.1% | +9.9% |
| BRTX | BUY | 2022-11-18 | 2022-11-21 | $2.88 | $3K | +41.7% | +11.8% | +9.9% |
| BRTX | BUY | 2022-09-22 | 2022-09-23 | $2.92 | $584 | +28.3% | +24.4% | +12.8% |
| BRTX | BUY | 2022-07-12 | 2022-07-13 | $2.95 | $2K | +3.4% | -1.6% | +14.1% |
| BRTX | BUY | 2022-06-30 | 2022-07-01 | $3.10 | $3K | -12.2% | -11.7% | -13.6% |
| BRTX | BUY | 2022-06-16 | 2022-06-17 | $3.73 | $2K | -12.7% | -13.3% | -8.2% |
| BRTX | BUY | 2022-06-15 | 2022-06-15 | $3.68 | $3K | -2.7% | -16.2% | -13.7% |
| BRTX | BUY | 2022-06-14 | 2022-06-15 | $3.91 | $2K | -2.7% | -16.2% | -13.7% |
| BRTX | BUY | 2022-06-13 | 2022-06-14 | $3.95 | $790 | -4.6% | -17.4% | -10.6% |
| BRTX | BUY | 2022-06-08 | 2022-06-09 | $4.28 | $428 | -23.8% | -26.0% | -25.2% |
| BRTX | BUY | 2022-06-01 | 2022-06-03 | $4.60 | $920 | -26.1% | -29.8% | -36.1% |
| BRTX | BUY | 2022-05-26 | 2022-05-27 | $3.52 | $10K | +7.1% | -7.9% | -11.5% |
| BRTX | BUY | 2022-05-02 | 2022-05-02 | $3.95 | $2K | -3.5% | +13.5% | -23.0% |
| BRTX | BUY | 2022-01-24 | 2022-01-24 | $3.40 | $5K | +2.9% | +36.3% | +5.2% |
| BRTX | BUY | 2022-01-05 | 2022-01-05 | $3.85 | $8K | +2.5% | +3.3% | +51.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.